Literature DB >> 13124349

Observations on the antirheumatic and physiologic effects of phenylbutazone (butazolidin) and some comparisons with cortisone.

B B BRODIE, E W LOWMAN, J J BURNS, P R LEE, T CHENKIN, A GOLDMAN, M WEINER, J M STEELE.   

Abstract

Entities:  

Keywords:  ANALGESICS/therapeutic use; ARTHRITIS, RHEUMATOID/therapy; CORTISONE/therapeutic use

Mesh：

Substances：

Year:  1954        PMID： 13124349     DOI： 10.1016/0002-9343(54)90333-2

Source DB:  PubMed          Journal:  Am J Med        ISSN： 0002-9343            Impact factor:   4.965


× No keyword cloud information.
  22 in total

1.  [PHENYLBUTAZONE AND CORTIN ACTION].

Authors:  H G MEIERS; W STAIB
Journal:  Klin Wochenschr       Date:  1965-05-15

2.  Evaluation of uricosuric agents in chronic gout.

Authors:  M A OGRYZLO; J HARRISON
Journal:  Ann Rheum Dis       Date:  1957-12       Impact factor: 19.103

3.  Recent advances in rheumatic diseases.

Authors:  E W BOLAND
Journal:  Calif Med       Date:  1955-02

4.  The effect of phenylbutazone on uric acid metabolism in two normal subjects.

Authors:  J B WYNGAARDEN
Journal:  J Clin Invest       Date:  1955-02       Impact factor: 14.808

5.  Metabolic effect of phenylbutazone in gouty and non-gouty arthritis.

Authors:  E R HUFFMAN; G M WILSON; C J SMYTH; R HILL
Journal:  Ann Rheum Dis       Date:  1954-12       Impact factor: 19.103

6.  The effect of bovine serum albumin on the in vitro inhibition of chemotaxis by anti-inflammatory agents.

Authors:  I Rivkin
Journal:  Agents Actions       Date:  1977-10

7.  Role of concentration-dependent plasma protein binding in disopyramide disposition.

Authors:  P J Meffin; E W Robert; R A Winkle; S Harapat; F A Peters; D C Harrison
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

Review 8.  Clinical pharmacokinetics of phenylbutazone.

Authors:  J Aarbakke
Journal:  Clin Pharmacokinet       Date:  1978 Sep-Oct       Impact factor: 6.447

9.  Phenylbutazone: a clinico-pharmacological study in rheumatoid arthritis.

Authors:  P M Brooks; J J Walker; W C Dick
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335

10.  Plasma concentration of phenylbutazone and its therapeutic effect-studies in patients with rheumatoid arthritis.

Authors:  M Orme; P J Holt; G R Hughes; C J Bulpitt; G H Draffan; S S Thorgeirsson; F Williams; D S Davies
Journal:  Br J Clin Pharmacol       Date:  1976-02       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.